New research uncovers how blood sugar levels — not time — drive diabetic eye disease, and maps the cell conversations behind it

New Research Uncovers How Blood Sugar Levels — Not Time — Drive Diabetic Eye Disease, and Maps the Cell Conversations Behind It

Article by Dr. Yong Ding | dingyong@jnu.edu.cn | Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Published in The Open Ophthalmology Journal, Volume 20, 03 March 2026

It's How High, Not How Long: Blood Sugar Levels Determine How Badly the Retina Suffers

Diabetic retinopathy — the leading cause of vision loss in people with diabetes — has long been understood as a complication that worsens the longer a person has the disease. A new study published in The Open Ophthalmology Journal challenges that assumption. By pooling and reanalyzing single-cell gene expression data from four independent research groups, covering both diabetic and healthy mice, researchers at Jinan University in China found that it is the actual blood sugar level at any given point, rather than how many years a person has had diabetes, that most reliably predicts how severely the retina is damaged. This finding held consistently across multiple cell types in the retina — including light-sensing cells, support cells, and signal-relaying cells — all of which showed gene activity patterns that tracked far more closely with blood glucose concentration than with how long the animals had been diabetic. The results were validated through laboratory experiments on diabetic mice, adding biological confirmation to the computational findings.

Three Types of Retinal Cells Are Actively "Talking" to Each Other Under High Blood Sugar

Going further, the research team zeroed in on how three key cell types in the retina — blood vessel lining cells (endothelial cells), the retina's resident immune cells (microglia), and signal-transmitting nerve cells (retinal ganglion cells) — behave and interact when blood glucose is dangerously high. Previous studies have largely focused on the inflammatory role of microglia in diabetic retinopathy, but this analysis told a different story: under extreme blood sugar conditions, the cross-talk between these three cell groups was more prominent than any immune response. Using cell communication analysis tools, the team traced two distinct, one-way signaling channels: endothelial cells send increased amounts of a protein called Igfbp3 to microglia through a receptor called Tmem219, and simultaneously reduce their output of another protein, Cxcl12, which reaches retinal ganglion cells via the Ackr3 receptor. Real-time laboratory tests on mouse retinal tissue confirmed that Igfbp3 and Cxcl12 behaved exactly as the data predicted. Critically, these two signaling pathways were found to be exclusive to endothelial cells — no other retinal cell type initiates them — pointing to the blood vessel lining as an early and active driver of retinal nerve damage in diabetes.

Why This Matters: New Targets for Earlier Detection and Treatment

Current treatments for diabetic retinopathy — including laser therapy and injections that block abnormal blood vessel growth — can only slow the disease down once it has already taken hold; they cannot reverse existing damage. That makes early detection and prevention the most important tools available. By mapping exactly how blood vessel cells signal to nerve and immune cells in the diabetic retina, this study points researchers toward specific molecular targets — particularly the Igfbp3-Tmem219 and Cxcl12-Ackr3 pathways — that could one day serve as early warning markers detectable in the eye, or as targets for treatments that intervene before irreversible vision loss begins. The study's authors note that the data were drawn from animal models rather than human patients, and call for future research using human retinal datasets to confirm and extend these findings. The research was led by corresponding author Dr. Yong Ding of the Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Tianhe District, Guangzhou, Guangdong Province, China.

Article Title: Endothelial Cells Communicate with Microglia and Retinal Ganglion Cells Through Igfbp3-Tmem219 and Cxcl12-Ackr3 Pathways in Diabetic Retinopathy

Read the published article here: https://bit.ly/4dCPf1x

JOURNAL

The Open Ophthalmology Journal

 DOI: 10.2174/0118743641422317260202062636

If you want to publish your article please visit : https://bit.ly/4de0DRi